中国科技核心期刊
CN:31-1600/Q
ISSN:1004-0374
“健康与疾病的免疫”国际学术研讨会通知      关于有网站冒充本刊网站的声明
《生命科学》 2012, 24(11): 1263-1269
我国药物临床试验伦理审查能力建设发展趋势
胡晋红
(第二军医大学长海医院伦理委员会,上海 200433)
摘 要:我国药物临床试验的深入广泛开展,促进了药物临床试验伦理审查水平的提高,伦理审查能力建设也取得了长足进步。但我国药物临床试验伦理审查能力建设面临系统的评估标准及体系、持续性培训和信息化程度缺乏等问题。加强药物临床试验伦理审查能力建设是我国医药领域进一步推进的重要工作,也是继续探索研究的热点内容及医学伦理审查工作者的自身需求。
关键词:药物;临床试验;伦理审查;能力建设
 
The development trendency of capacity development of ethical review of drug clinical trial in China
HU Jin-Hong
(Ethics Committee of Changhai Hospital, Second Military Medical University, Shanghai 200433, China)

Abstract: With the development of the clinical trial being carried out widely in our country, the reviewing capacity and its construction ability of drug clinical trial are also growing. However, problems still exist in fields of evaluation criteria, system, continuous training and informatization. As a result, the construction of promoting the ethical reviewing capacity in drug clinical trials becomes an important task and focus of the further study, as well as the need of EC members.
Key words: drugs; clinical trials; ethical review; capacity construction

 
首页 | 刊物简介 | 编委会 | 投稿须知 | 广告业务 | 过刊浏览 | 联系我们
中国科学院上海生命科学信息中心《生命科学》编辑部
Copyright © 2012-2015 《生命科学》编辑部 All Rights Reserved.
沪ICP备05033115号-30
您是第2986105 位访问者,欢迎!